Login Register Cart 0
Generic placeholder image

Current Hypertension Reviews

Editor-in-Chief

ISSN (Print): 1573-4021
ISSN (Online): 1875-6506

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Ca2+/cAMP Ratio as an Inflammatory Index

Author(s): Leandro Bueno Bergantin*

Volume 19, Issue 1, 2023

Published on: 16 December, 2022

Page: [4 - 6] Pages: 3

DOI: 10.2174/1573402119666221202145753

« Previous Next »
[1]
Chou CW, Fang WH, Chen YY, et al. Association between serum calcium and risk of cardiometabolic disease among community-dwelling adults in Taiwan. Sci Rep 2020; 10(1): 3192.
[http://dx.doi.org/10.1038/s41598-020-60209-w] [PMID: 32081877]
[2]
Bergantin LB. Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3′-5′-cyclic adenosine monophosphate signaling. World J Diabetes 2021; 12(6): 767-79.
[http://dx.doi.org/10.4239/wjd.v12.i6.767] [PMID: 34168726]
[3]
Bergantin LB. Hypertension, diabetes and neurodegenerative diseases: Is there a clinical link through the Ca2+/cAMP signalling interaction? Curr Hypertens Rev 2019; 15(1): 32-9.
[http://dx.doi.org/10.2174/1573402114666180817113242] [PMID: 30117399]
[4]
Caricati-Neto A, García AG, Bergantin LB. Pharmacological implications of the Ca2+/cAMP signaling interaction: From risk for antihyper-tensive therapy to potential beneficial for neurological and psychiatric disorders. Pharmacol Res Perspect 2015; 3(5): e00181.
[http://dx.doi.org/10.1002/prp2.181] [PMID: 26516591]
[5]
Bergantin LB. A timeline of Ca2+/cAMP signalling: From basic research to potential therapeutics for dementia. Curr Alzheimer Res 2022; 19(3): 179-87.
[http://dx.doi.org/10.2174/1567205019666220415125447] [PMID: 35430979]
[6]
Bergantin LB. The interactions among hypertension, cancer, and COVID-19: Perspective with regard to Ca2+/cAMP signalling. Curr Cancer Drug Targets 2022; 22(5): 351-60.
[http://dx.doi.org/10.2174/1568009622666220215143805] [PMID: 35168520]
[7]
Miranda-Ferreira R, de Pascual R, de Diego AMG, et al. Single-vesicle catecholamine release has greater quantal content and faster kinetics in chromaffin cells from hypertensive, as compared with normotensive, rats. J Pharmacol Exp Ther 2008; 324(2): 685-93.
[http://dx.doi.org/10.1124/jpet.107.128819] [PMID: 17962518]
[8]
Rooney MR, Pankow JS, Sibley SD, et al. Serum calcium and incident type 2 diabetes: The Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr 2016; 104(4): 1023-9.
[http://dx.doi.org/10.3945/ajcn.115.130021] [PMID: 27510541]
[9]
Begum N, Leitner W, Reusch JE, Sussman KE, Draznin B. GLUT-4 phosphorylation and its intrinsic activity. Mechanism of Ca(2+)-induced inhibition of insulin-stimulated glucose transport. J Biol Chem 1993; 268(5): 3352-6.
[http://dx.doi.org/10.1016/S0021-9258(18)53701-7] [PMID: 8381427]
[10]
Bergantin LB. Debating the “bidirectional link” between diabetes and depression through the Ca2+/cAMP signalling: Off-label effects of Ca2+ channel blockers. Pharmacol Res 2019; 141: 298-302.
[http://dx.doi.org/10.1016/j.phrs.2019.01.008] [PMID: 30639385]
[11]
Abdi A, Jalilian M, Sarbarzeh PA, Vlaisavljevic Z. Diabetes and COVID-19: A systematic review on the current evidences. Diabetes Res Clin Pract 2020; 166: 108347.
[http://dx.doi.org/10.1016/j.diabres.2020.108347] [PMID: 32711003]
[12]
Olivier M. Modulation of host cell intracellular Ca2+. Parasitol Today 1996; 12(4): 145-50.
[http://dx.doi.org/10.1016/0169-4758(96)10006-5] [PMID: 15275223]
[13]
Nugent KM, Shanley JD. Verapamil inhibits influenza A virus replication. Arch Virol 1984; 81(1-2): 163-70.
[http://dx.doi.org/10.1007/BF01309305] [PMID: 6743023]
[14]
Dionicio CL, Peña F, Constantino-Jonapa LA, et al. Dengue virus induced changes in Ca2+ homeostasis in human hepatic cells that favor the viral replicative cycle. Virus Res 2018; 245: 17-28.
[http://dx.doi.org/10.1016/j.virusres.2017.11.029] [PMID: 29269104]
[15]
Scherbik SV, Brinton MA. Virus-induced Ca2+ influx extends survival of west nile virus-infected cells. J Virol 2010; 84(17): 8721-31.
[http://dx.doi.org/10.1128/JVI.00144-10] [PMID: 20538858]
[16]
Goldberg ML, Bohannon NV, Brooks RM, Tsalikian E, Lorenzi M, Forsham PH. Plasma cyclic nucleotide levels in juvenile-onset diabetes. Diabetes 1977; 26(10): 936-43.
[http://dx.doi.org/10.2337/diab.26.10.936] [PMID: 198321]
[17]
Nagao M, Lagerstedt JO, Eliasson L. Secretory granule exocytosis and its amplification by cAMP in pancreatic β-cells. Diabetol Int 2022; 13(3): 471-9.
[http://dx.doi.org/10.1007/s13340-022-00580-3] [PMID: 35694000]
[18]
Mazeaud MM, Quan Sang K-HL, Devynck MA. Platelet cyclic AMP in essential hypertension. J Hypertens 1989; 7(6): 501-6.
[http://dx.doi.org/10.1097/00004872-198906000-00010] [PMID: 2550542]
[19]
Blanco-Rivero J, Xavier FE. Therapeutic potential of phosphodiesterase inhibitors for endothelial dysfunction- Related diseases. Curr Pharm Des 2020; 26(30): 3633-51.
[http://dx.doi.org/10.2174/1381612826666200403172736] [PMID: 32242780]

Rights & Permissions Print Cite
Article Metrics
21
1
© 2024 Bentham Science Publishers | Privacy Policy